Castle Biosciences study finds TissueCypher changed Barrett’s care decisions 90% of the time
AI Summary- Castle Biosciences published a study on TissueCypher-guided management for non-dysplastic Barrett’s esophagus.
- 90% of clinicians changed management recommendations after receiving TissueCypher results.
- The study evaluated 30 patients at Keck Medical Center of USC.